VTVT

Companies
NASDAQ
vTv Therapeutics Inc.
Health Care
Price Chart
Overview

About VTVT

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

Market Cap
$41.6M
Volume
222.2K
Avg. Volume
586.6K
P/E Ratio
-47.878788
Dividend Yield
0.00%
Employees
35.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
1.23
Moderate Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for VTVT.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, VTVT shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$41.6M
Volume222.2K
P/E Ratio-47.88
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 21, 2025

PortfolioPilot Analysis

Get AI-powered insights on how VTVT fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025